Erwan Sallard

991 total citations
19 papers, 609 citations indexed

About

Erwan Sallard is a scholar working on Infectious Diseases, Molecular Biology and Genetics. According to data from OpenAlex, Erwan Sallard has authored 19 papers receiving a total of 609 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Infectious Diseases, 7 papers in Molecular Biology and 6 papers in Genetics. Recurrent topics in Erwan Sallard's work include SARS-CoV-2 and COVID-19 Research (6 papers), Virus-based gene therapy research (6 papers) and CAR-T cell therapy research (3 papers). Erwan Sallard is often cited by papers focused on SARS-CoV-2 and COVID-19 Research (6 papers), Virus-based gene therapy research (6 papers) and CAR-T cell therapy research (3 papers). Erwan Sallard collaborates with scholars based in Germany, France and United Kingdom. Erwan Sallard's co-authors include Nathan Peiffer‐Smadja, François-Xavier Lescure, Yazdan Yazdanpanah, France Mentré, Pascal Legendre, Jacques van Helden, Étienne Decroly, José Halloy, Didier Casañe and Anja Ehrhardt and has published in prestigious journals such as SHILAP Revista de lepidopterología, Cellular and Molecular Life Sciences and Journal of Antimicrobial Chemotherapy.

In The Last Decade

Erwan Sallard

18 papers receiving 596 citations

Peers

Erwan Sallard

NEURO

IMMUN

GENET

Alan H. M. Wong Canada

Edoardo Schneider Italy

Man Chun Cheung Hong Kong

Matthew Grunewald United States

Abigail Vanderheiden United States

Muktha S. Natrajan United States

Yun Tian China

Kathy Manguiat Canada

Luxin Qiao China

Lei Fang China

Alan H. M. Wong Canada

Erwan Sallard

384 ×1.0

289 ×2.0

NEURO

132 ×1.0

86 ×1.1

IMMUN

40 ×0.5

GENET

Citations per year, relative to Erwan Sallard Erwan Sallard (= 1×) peers Alan H. M. Wong

Countries citing papers authored by Erwan Sallard

Since Specialization

Citations

This map shows the geographic impact of Erwan Sallard's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Erwan Sallard with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Erwan Sallard more than expected).

Fields of papers citing papers by Erwan Sallard

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Erwan Sallard. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Erwan Sallard. The network helps show where Erwan Sallard may publish in the future.

Co-authorship network of co-authors of Erwan Sallard

This figure shows the co-authorship network connecting the top 25 collaborators of Erwan Sallard. A scholar is included among the top collaborators of Erwan Sallard based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Erwan Sallard. Erwan Sallard is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

19 of 19 papers shown

Sallard, Erwan, L.E.R. Dawson, Eric Ehrke‐Schulz, et al.. (2024). ADEVO: Proof-of-concept of adenovirus-directed EVOlution by random peptide display on the fiber knob. SHILAP Revista de lepidopterología. 32(4). 200867–200867. 1 indexed citations

Sallard, Erwan & Malik Aydin. (2024). Cutting-edge research frontiers in oral cavity vaccines for respiratory diseases: a roadmap for scientific advancement. Frontiers in Cellular and Infection Microbiology. 14. 1388222–1388222.

Sallard, Erwan, et al.. (2024). Combining CRISPR-Cas-mediated terminal resolution with a novel genetic workflow to achieve high-diversity adenoviral libraries. Molecular Therapy — Methods & Clinical Development. 32(2). 101241–101241. 3 indexed citations

Mautner, Lena, Mona Hoyos, Erwan Sallard, et al.. (2023). In Vitro Analysis of the Effect of SARS-CoV-2 Non-VOC and four Variants of Concern on MHC-Class-I Expression on Calu-3 and Caco-2 Cells. Genes. 14(7). 1348–1348. 3 indexed citations

Sallard, Erwan, Alexander E. Klimovitskii, Claudia Hagedorn, et al.. (2023). Development of oncolytic and gene therapy vectors based on adenovirus serotype 4 as an alternative to adenovirus serotype 5. The Journal of Gene Medicine. 26(1). e3576–e3576. 2 indexed citations

Sallard, Erwan, et al.. (2023). The Adenovirus Vector Platform: Novel Insights into Rational Vector Design and Lessons Learned from the COVID-19 Vaccine. Viruses. 15(1). 204–204. 22 indexed citations

Sallard, Erwan, Katarzyna Niespodziana, Thomas Schlederer, et al.. (2022). Microarray-Based Analyses of Rhinovirus Species-Specific Antibody Responses in Exacerbated Pediatric Asthma in a German Pediatric Cohort. Viruses. 14(9). 1857–1857. 2 indexed citations

Westhaus, Adrian, Erwan Sallard, Erhua Zhu, et al.. (2022). AAV-p40 Bioengineering Platform for Variant Selection Based on Transgene Expression. Human Gene Therapy. 33(11-12). 664–682. 20 indexed citations

Khan, Shaheen & Erwan Sallard. (2022). Current and Prospective Applications of CRISPR-Cas12a in Pluricellular Organisms. Molecular Biotechnology. 65(2). 196–205. 12 indexed citations

10.

Sallard, Erwan, Parviz Ahmad‐Nejad, Beniam Ghebremedhin, et al.. (2022). Viral Infection and Respiratory Exacerbation in Children: Results from a Local German Pediatric Exacerbation Cohort. Viruses. 14(3). 491–491. 7 indexed citations

11.

Sallard, Erwan, José Halloy, Didier Casañe, Étienne Decroly, & Jacques van Helden. (2021). Tracing the origins of SARS-COV-2 in coronavirus phylogenies: a review. Environmental Chemistry Letters. 19(2). 769–785. 36 indexed citations

12.

Sallard, Erwan, et al.. (2021). Simplified Point-of-Care Full SARS-CoV-2 Genome Sequencing Using Nanopore Technology. Microorganisms. 9(12). 2598–2598. 13 indexed citations

13.

Sallard, Erwan, et al.. (2021). Electrophysiology of ionotropic GABA receptors. Cellular and Molecular Life Sciences. 78(13). 5341–5370. 81 indexed citations

14.

Sallard, Erwan, Drifa Belhadi, F.-X. Lescure, Yazdan Yazdanpanah, & Nathan Peiffer‐Smadja. (2020). Clinical trial protocols of repurposed prophylaxis for COVID-19: A review. Infectious Diseases Now. 51(1). 7–13. 4 indexed citations

15.

Cabanes‐Creus, Marti, Adrian Westhaus, Erhua Zhu, et al.. (2020). Attenuation of Heparan Sulfate Proteoglycan Binding Enhances In Vivo Transduction of Human Primary Hepatocytes with AAV2. Molecular Therapy — Methods & Clinical Development. 17. 1139–1154. 31 indexed citations

16.

Sallard, Erwan, François-Xavier Lescure, Yazdan Yazdanpanah, France Mentré, & Nathan Peiffer‐Smadja. (2020). Type 1 interferons as a potential treatment against COVID-19. Antiviral Research. 178. 104791–104791. 354 indexed citations

17.

Sallard, Erwan, José Halloy, Didier Casañe, Jacques van Helden, & Étienne Decroly. (2020). Retrouver les origines du SARS-CoV-2 dans les phylogénies de coronavirus. médecine/sciences. 36(8-9). 783–796. 11 indexed citations

18.

Peiffer‐Smadja, Nathan, et al.. (2020). Anticovid, a comprehensive open-access real-time platform of registered clinical studies for COVID-19. Journal of Antimicrobial Chemotherapy. 75(9). 2708–2710. 6 indexed citations

19.

Sallard, Erwan, François-Xavier Lescure, Charles Burdet, et al.. (2020). Repurposed prophylaxis strategies for COVID-19: a review. medRxiv. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact